BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30

BECTON DICKINSON & CO

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$190.74−1.01 (-0.53%)

Close on Oct 19, 2026

Community

Notes and questions about Becton Dickinson from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Becton Dickinson's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Aug 21, 1998
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BDX.

Revenue growth17.4% · median 6.9%

Gross margin46.9% · median 59.8%

Operating margin10.7% · median 20.6%

Net margin4.0% · median 14.4%

Advertisement
300 × 250